SCHEMBL9749852

SCHEMBL9749852

COC(=O)CCc1nsnc1OCC(O)CNC(C)(C)CO

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRB3 P13945 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD1 P21728 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
BLM P54132 1/20 0.40
PKM P14618 1/20 0.38
CASR P41180 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10997074 0.91 CASR (0.41) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL9749804 0.90 ADRB2 (0.50) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL10984749 0.87 ADRB2 (0.43) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL11756802 0.83 CYP2D6 (0.46) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL11756794 0.83 CYP2D6 (0.46) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL9749867 0.82 ADRB2 (0.56) ADRB2ADRB1CYP2D6CYP1A2HTR1A
SCHEMBL9749811 0.80 ADRB2 (0.47) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL10979024 0.80 ADRB2 (0.50) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL9749902 0.80 SMN1; SMN2 (0.52) ADRB2ADRB1CYP2D6CYP1A2CYP3A4
SCHEMBL10992536 0.80 CYP1A2 (0.42) ADRB2ADRB1CYP2D6CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed